In the preceding three months, 9 analysts have released ratings for TransMedics Gr (NASDAQ:TMDX), presenting a wide array of perspectives from bullish to bearish.
Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.
Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
---|---|---|---|---|---|
Total Ratings | 3 | 6 | 0 | 0 | 0 |
Last 30D | 0 | 1 | 0 | 0 | 0 |
1M Ago | 1 | 1 | 0 | 0 | 0 |
2M Ago | 2 | 3 | 0 | 0 | 0 |
3M Ago | 0 | 1 | 0 | 0 | 0 |
Analysts have recently evaluated TransMedics Gr and provided 12-month price targets. The average target is $128.89, accompanied by a high estimate of $175.00 and a low estimate of $95.00. Observing a 19.19% increase, the current average has risen from the previous average price target of $108.14.
Diving into Analyst Ratings: An In-Depth Exploration
In examining recent analyst actions...
Login or create a forever free account to read this news
Sign up/Log in